<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="68569">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02213185</url>
  </required_header>
  <id_info>
    <org_study_id>O-9-2013</org_study_id>
    <nct_id>NCT02213185</nct_id>
  </id_info>
  <brief_title>EMLA and Sterile Water Injections - Pain From Injections</brief_title>
  <official_title>Effect of EMLA® Patches for Reducing Pain Associated With Sterile Water Injections - a Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Skövde</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Skövde</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim is to study the effect of local anaesthesia (EMLA®) on pain associated with sterile
      water injections.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Sterile Water Injection (SWI) was previously shown to give good pain relief for lower-back
      pain during childbirth, chronic neck pain and ureterolithiasis. However, the pain associated
      with the injections remains problematic, and therefore it is important to find a less
      painful injection technique.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2014</start_date>
  <completion_date type="Anticipated">June 2017</completion_date>
  <primary_completion_date type="Anticipated">June 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single Blind (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Injection pain measured by VAS following Sterile Water Injections</measure>
    <time_frame>15 minutes</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Self reported experiences of the injections and side effects</measure>
    <time_frame>24 hours</time_frame>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Pain</condition>
  <arm_group>
    <arm_group_label>EMLA patches and SWI</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>EMLA patches 1.5 hrs before sterile water injections</description>
  </arm_group>
  <arm_group>
    <arm_group_label>EMLA patches and isotonic saline</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>EMLA patches 1.5 hrs before isotonic saline</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo patches and SWI</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>PLACEBO patches 1.5 hrs before sterile water injections</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo patches and isotonic saline</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>PLACEBO patches 1.5 hrs before isotonic saline</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>EMLA patches</intervention_name>
    <description>EMLA patches 1.5 hrs before sterile water injections</description>
    <arm_group_label>EMLA patches and SWI</arm_group_label>
    <arm_group_label>EMLA patches and isotonic saline</arm_group_label>
    <arm_group_label>Placebo patches and SWI</arm_group_label>
    <arm_group_label>Placebo patches and isotonic saline</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria

          -  Woman

          -  Age 18-45 years

          -  Healthy

          -  Ability to understand information and instructions

        Exclusion Criteria:

          -  Pregnancy

          -  Previous experience of SWI

          -  On-going pain

          -  Use of medication for depression, pain, or sleeping disorder 24 hours prior to the
             experiment

          -  Smoking, snuffing, physical activity, and intake of caffeinated beverages (coffee,
             tea, or energy drink (e.g., Red Bull) 2 hours prior to the experiment
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lena B Mårtensson, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Skövde</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Lena B Mårtensson, Professor</last_name>
    <phone>+46500 44 80 00</phone>
    <phone_ext>8450</phone_ext>
    <email>lena.martensson@his.se</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ingrid Bergh, Professor</last_name>
    <phone>+46500 44 80 00</phone>
    <phone_ext>8452</phone_ext>
    <email>ingrid.bergh@his.se</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>School of Health and Education, University of Skövde</name>
      <address>
        <city>Skövde</city>
        <zip>SE-541 28</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ingrid Bergh, PhD</last_name>
      <phone>+46 500 44 80 00</phone>
      <phone_ext>8452</phone_ext>
      <email>ingrid.bergh@his.se</email>
    </contact>
    <contact_backup>
      <last_name>Lena B Mårtensson, PhD</last_name>
      <phone>+46 500 44 80 00</phone>
      <phone_ext>8450</phone_ext>
      <email>lena.martensson@his.se</email>
    </contact_backup>
    <investigator>
      <last_name>Ingrid Bergh, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Lena B Mårtensson, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>November 2016</verification_date>
  <lastchanged_date>November 19, 2016</lastchanged_date>
  <firstreceived_date>August 7, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Skövde</investigator_affiliation>
    <investigator_full_name>Lena B Martensson</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>Sterile water injections</keyword>
  <keyword>Pain</keyword>
  <keyword>VAS</keyword>
  <keyword>Complementary method</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Infertility</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>EMLA</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
